[EN] PYRIDINE, PYRAZINE, AND TRIAZINE COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS<br/>[FR] PYRIDINE, PYRAZINE ET COMPOSÉS DE TRIAZINE UTILISÉS EN TANT QU'INHIBITEURS ALLOSTÉRIQUES DE SHP2
申请人:REVOLUTION MEDICINES INC
公开号:WO2019075265A1
公开(公告)日:2019-04-18
The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
本公开涉及SHP2的
抑制剂及其在疾病治疗中的应用。同时还披露了包含这些
抑制剂的药物组合物。